Myelodysplastic Syndrome Related to Successful Treatment With177Lu-PSMA for Metastatic Castration–Refractory Prostate Cancer

Lavinia Vija Racaru, Mehdi Krim, Valérian Rivet, Loic Mourey, Pr Frederic Courbon

Open source

DOI
10.1097/rlu.0000000000005251
Published
2024-05-20
Container
Clinical Nuclear Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/rlu.0000000000005251,
  title = {Myelodysplastic Syndrome Related to Successful Treatment With177Lu-PSMA for Metastatic Castration–Refractory Prostate Cancer},
  author = {Lavinia Vija Racaru and Mehdi Krim and Valérian Rivet and Loic Mourey and Pr Frederic Courbon},
  year = {2024},
  journal = {Clinical Nuclear Medicine},
  doi = {10.1097/rlu.0000000000005251},
  url = {https://doi.org/10.1097/rlu.0000000000005251}
}

RIS

TY  - JOUR
TI  - Myelodysplastic Syndrome Related to Successful Treatment With177Lu-PSMA for Metastatic Castration–Refractory Prostate Cancer
AU  - Lavinia Vija Racaru
AU  - Mehdi Krim
AU  - Valérian Rivet
AU  - Loic Mourey
AU  - Pr Frederic Courbon
PY  - 2024
JO  - Clinical Nuclear Medicine
DO  - 10.1097/rlu.0000000000005251
UR  - https://doi.org/10.1097/rlu.0000000000005251
ER  - 

APA

Racaru, L. V., Krim, M., Rivet, V., Mourey, L., & Courbon, P. F. (2024). Myelodysplastic Syndrome Related to Successful Treatment With177Lu-PSMA for Metastatic Castration–Refractory Prostate Cancer. Clinical Nuclear Medicine. https://doi.org/10.1097/rlu.0000000000005251

Source records